Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 FDA Record
- Latest inspection VAI · Jun 16, 2026
- No warning letters matched by name
Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6" is on file.
- Latest inspection
- Jun 16, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 1 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 16, 2026 | Xinxiang, China | Drugs | Voluntary Action Indicated (VAI) | 3041598181 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3041598181 | Xinxiang, China | 1 | Jun 16, 2026 |
Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 and the FDA: common questions
Has Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 received an FDA warning letter?
No FDA warning letter addressed to the name "Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 received an FDA Form 483?
FDA has not published a Form 483 for "Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6?
The most recent FDA inspection on file ended Jun 16, 2026 at Xinxiang, China and was classified VAI. FDA has 1 inspection of Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 on file.
Need more than this page shows? Ask about Shenzhen Haibin Pharmaceutical Co., Ltd. Off-Site Workshop 6 in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.